We are live on ! Find out more
EIM

Essex Investment Management Portfolio holdings

AUM $632M
1-Year Est. Return 95.36%
This Fund
S&P 500
This Quarter Est. Return
+6.91%
1 Year Est. Return
+95.36%
3 Year Est. Return
+271.62%
5 Year Est. Return
+354.98%
10 Year Est. Return
+3,586.14%
AUM
$535M
AUM Growth
+$28M
Cap. Flow
+$20.7M
Cap. Flow %
3.87%
Top 10 Hldgs %
17.17%
Holding
336
New
30
Increased
83
Reduced
125
Closed
34

Top Buys

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$5.63M
2
MYGN icon
Myriad Genetics
MYGN
+$5.27M
3
AMBA icon
Ambarella
AMBA
+$4.33M
4
EVER icon
EverQuote
EVER
+$3.93M
5
AGX icon
Argan
AGX
+$3.72M

Top Sells

Rank Stock Value
1
DGII icon
Digi International
DGII
+$7.01M
2
COUR icon
Coursera
COUR
+$5.05M
3
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$4.54M
4
ICHR icon
Ichor Holdings
ICHR
+$4.04M
5
KRUS icon
Kura Sushi USA
KRUS
+$3.31M

Sector Composition

Rank Sector Weight
1 Industrials 28.91%
2 Technology 24.08%
3 Healthcare 20.66%
4 Financials 5.77%
5 Consumer Discretionary 5.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WTS icon
301
Watts Water Technologies
WTS
$12.8B
$917 ﹤0.01%
5
-16
-76% -$3.21K
ARAY icon
302
Accuray
ARAY
$32.9M
– –
-665,842
Closed -$1.64M
BLZE icon
303
Backblaze
BLZE
$1.23B
– –
-200,219
Closed -$2.05M
BR icon
304
Broadridge
BR
$19.2B
– –
-18
Closed -$3.69K
BTG icon
305
B2Gold
BTG
$6.72B
– –
-10,000
Closed -$26.1K
CCS icon
306
Century Communities
CCS
$2.03B
– –
-28,174
Closed -$2.72M
COUR icon
307
Coursera
COUR
$1.49B
– –
-360,462
Closed -$5.05M
CSBR icon
308
Champions Oncology
CSBR
$67.8M
– –
-77,200
Closed -$378K
CTSH icon
309
Cognizant
CTSH
$26.1B
– –
-165
Closed -$12.1K
DGII icon
310
Digi International
DGII
$3.21B
– –
-219,515
Closed -$7.01M
DOCS icon
311
Doximity
DOCS
$4.49B
– –
-2,723
Closed -$73.3K
ET icon
312
Energy Transfer Partners
ET
$72.7B
– –
-2,987
Closed -$47K
FENC icon
313
Fennec Pharmaceuticals
FENC
$428M
– –
-144,218
Closed -$1.6M
GAU
314
Galiano Gold
GAU
$544M
– –
-20,000
Closed -$28K
GENI icon
315
Genius Sports
GENI
$2.15B
– –
-15,092
Closed -$86.2K
HCAT icon
316
Health Catalyst
HCAT
$132M
– –
-245,429
Closed -$1.85M
ICHR icon
317
Ichor Holdings
ICHR
$2.69B
– –
-104,736
Closed -$4.04M
KOPN icon
318
Kopin
KOPN
$901M
– –
-1,224,056
Closed -$2.2M
KRUS icon
319
Kura Sushi USA
KRUS
$636M
– –
-28,751
Closed -$3.31M
MYRG icon
320
MYR Group
MYRG
$5.17B
– –
-7,686
Closed -$1.36M
ORI icon
321
Old Republic International
ORI
$10.3B
– –
-1
Closed -$26
SANW
322
DELISTED
S&W Seed Co
SANW
– –
-18,078
Closed -$166K
SHW icon
323
Sherwin-Williams
SHW
$87.2B
– –
-36
Closed -$12.5K
TDUP icon
324
ThredUp
TDUP
$407M
– –
-337,945
Closed -$676K
TPVG icon
325
TriplePoint Venture Growth BDC
TPVG
$218M
– –
-108
Closed -$1.02K
10 11 12
13
14

Similar funds

BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
AP
Affinity Partners Sunny Isles Beach, Florida $635M AUM 43.43% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
WCM
Woodson Capital Management Greenwich, Connecticut $636M AUM 39.33% 1-Year Est. Return
FTC
Farmers Trust Company Youngstown, Ohio $637M AUM 23.14% 1-Year Est. Return

Essex Investment Management's Q2 2024 Portfolio in Review

As of Q2 2024, Essex Investment Management held 336 positions worth $535M, up 5.5% from $507M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Essex Investment Management deployed $20.7M of net new capital in Q2 2024, opening 30 new positions and adding to 83 existing holdings. Its largest new stake was Ligand Pharmaceuticals: 70,780 shares worth $5.96M.

By sector, the portfolio is most concentrated in Industrials at 29% of assets, up from 26% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Aspen Aerogels, an estimated $2.12M trimmed.

  • Essex Investment Management's largest Q2 2024 buy was Ligand Pharmaceuticals: 70,780 shares worth $5.96M.
  • Essex Investment Management added most to AvePoint in Q2 2024, an estimated $3.22M increase.
  • Essex Investment Management's biggest Q2 2024 reduction was Aspen Aerogels, cutting an estimated $2.12M.
  • Essex Investment Management fully exited Digi International in Q2 2024, selling an estimated $7.01M.
  • Essex Investment Management's ten largest holdings make up 17% of its $535M portfolio in Q2 2024.
  • Essex Investment Management opened 30 new positions and closed 34 in Q2 2024.
  • Essex Investment Management's portfolio value rose 5.5% quarter-over-quarter to $535M.

Based on Essex Investment Management's 13F filing for Q2 2024, filed 12 Aug 2024.